Ronald E. Frieson's most recent trade in Akebia Therapeutics Inc. was a trade of 53,600 Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 53,600 | 53,600 | - | - | Stock Option (Right to buy) | |
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 35,700 | 129,500 (0%) | 0% | 0 | Common Stock | |
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. | 17 Jan 2025 | 20,100 | 93,800 (0%) | 0% | 0.5 | 9,045 | Common Stock |
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2025 | 20,100 | 0 | - | - | Stock Option (Right to buy) | |
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 30,000 | 73,700 (0%) | 0% | 0 | Common Stock | |
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to buy) | |
Akebia Therapeutics Inc. | Ronald E. Frieson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,000 | 43,700 (0%) | 0% | 0 | Common Stock |